COMBINED TREATMENT OF MULTIPLE SCLEROSIS

摘要

The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage ofEP0003504of GH together with IFN-.beta. to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.